An emerging view on vascular fibrosis molecular mediators and relevant disorders: from bench to bed.
CVD
ECM
RAAS
TGF-β
arterial stiffness
vascular fibrosis
Journal
Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388
Informations de publication
Date de publication:
2023
2023
Historique:
received:
06
08
2023
accepted:
27
11
2023
medline:
5
1
2024
pubmed:
5
1
2024
entrez:
5
1
2024
Statut:
epublish
Résumé
Vascular fibrosis is a widespread pathologic condition that arises during vascular remodeling in cardiovascular dysfunctions. According to previous studies, vascular fibrosis is characterized by endothelial matrix deposition and vascular wall thickening. The RAAS and TGF-β/Smad signaling pathways have been frequently highlighted. It is, however, far from explicit in terms of understanding the cause and progression of vascular fibrosis. In this review, we collected and categorized a large number of molecules which influence the fibrosing process, in order to acquire a better understanding of vascular fibrosis, particularly of pathologic dysfunction. Furthermore, several mediators that prevent vascular fibrosis are discussed in depth in this review, with the aim that this will contribute to the future prevention and treatment of related conditions.
Identifiants
pubmed: 38179503
doi: 10.3389/fcvm.2023.1273502
pmc: PMC10764515
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
1273502Informations de copyright
© 2023 Hua, Gao, He, Xin, Wang, Zhang, Gao, Tao, Wu, Sun and Xu.
Déclaration de conflit d'intérêts
The author(s) declare financial support was received for the research, authorship, and/or publication of this article.